136 related articles for article (PubMed ID: 327183)
1. Ergolines as potential prolactin and mammary tumor inhibitors.
Cassady JM; Floss HG
Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
[No Abstract] [Full Text] [Related]
2. Drug therapy: Bromocriptine.
Parkes D
N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
[No Abstract] [Full Text] [Related]
3. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Boyd AE; Reighlin S
N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
[No Abstract] [Full Text] [Related]
4. Bromocriptine - an important advance.
Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
[No Abstract] [Full Text] [Related]
5. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
6. Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
Vigneri R; Goldfine ID
Adv Intern Med; 1980; 25():69-89. PubMed ID: 6102431
[No Abstract] [Full Text] [Related]
7. Bromocriptine update.
Borowski GD; Rose LI
Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
[No Abstract] [Full Text] [Related]
8. Recent studies on functions and control of prolactin secretion in rats.
Meites J; Lu KH; Wuttke W; Welsch CW; Nagasawa H; Quadri SK
Recent Prog Horm Res; 1972; 28():471-526. PubMed ID: 4569231
[No Abstract] [Full Text] [Related]
9. Bromocriptine--a versatile remedy.
Joffe BI; Distiller LA; Seftel HC
S Afr Med J; 1977 Jun; 51(26):954-5. PubMed ID: 578015
[No Abstract] [Full Text] [Related]
10. Editorial: Bromocriptine.
Lancet; 1975 May; 1(7915):1076. PubMed ID: 48738
[No Abstract] [Full Text] [Related]
11. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Abraham G
Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
[No Abstract] [Full Text] [Related]
12. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
[TBL] [Abstract][Full Text] [Related]
13. [Bromocriptine (Parlodel). A prolactin inhibiting dopamine receptor agonist].
Andersen AN
Ugeskr Laeger; 1977 May; 139(22):1311-3. PubMed ID: 577320
[No Abstract] [Full Text] [Related]
14. Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
Besser GM; Thorner MO
Postgrad Med J; 1976; 52suppl 1():64-70. PubMed ID: 959127
[No Abstract] [Full Text] [Related]
15. [Bromocryptin in obstetrics and gynecology].
Alipov VI; Beskrovnaia NI
Akush Ginekol (Mosk); 1980 Jul; (7):3-6. PubMed ID: 6998309
[No Abstract] [Full Text] [Related]
16. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
[No Abstract] [Full Text] [Related]
17. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Frantz AG; Kleinberg DL
Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine.
Med Lett Drugs Ther; 1977 Dec; 19(25):103-4. PubMed ID: 593228
[No Abstract] [Full Text] [Related]
19. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
Netter A; Netter AL; Gorins A
Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
[No Abstract] [Full Text] [Related]
20. [Parlodel. Mechanism of action and use].
Marova EI; Egart FM; Pronin VS; Mel'nichenko GA
Probl Endokrinol (Mosk); 1985; 31(3):85-92. PubMed ID: 3903743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
